RSSL genotyping service
RSSL-Pharma has launched a new service in high throughput genetic screening that will enable pharmaceutical companies to outsource the genotyping of clinical samples, used to identify the genetic factors associated with propagation of disease.
According to Dr Andrew Tingey, head of molecular biology at RSSL, 'The service will be of particular interest to companies that need to scale up screening of samples using established assays for the detection of single nucleotide polymorphisms (SNPs).'